Corvus Pharmaceuticals, Inc.·4

Dec 20, 6:22 PM ET

Jones William Benton 4

4 · Corvus Pharmaceuticals, Inc. · Filed Dec 20, 2022

Insider Transaction Report

Form 4
Period: 2022-12-20
Transactions
  • Purchase

    Common Stock

    2022-12-20$0.79/sh+20,000$15,800133,773 total
Signature
/s/ Leiv Lea, as Attorney-in-Fact for William Benton Jones, Ph.D.|2022-12-20

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4